Abstract:Since the discovery of Stimulator of Interferon Genes (STING) as an important pivot for cytosolic DNA sensation and interferon (IFN) induction, intensive efforts have been endeavored to clarify the molecular mechanism of its activation, its physiological function as a ubiquitously expressed protein, and to explore its potential as a therapeutic target in a wide range of immune-related diseases. With its orthodox ligand 2'3'-cyclic GMP–AMP (2'3'-cGAMP) and the upstream sensor 2'3'-cGAMP synthase (cGAS) to be found, STING acquires its central functionality in the best-studied signaling cascade, namely the cGAS–STING–IFN pathway. However, recently updated research through structural research, genetic screening, and biochemical assay greatly extends the current knowledge of STING biology. A second ligand pocket was recently discovered in the transmembrane domain for a synthetic agonist. On its downstream outputs, accumulating studies sketch primordial and multifaceted roles of STING beyond its cytokine-inducing function, such as autophagy, cell death, metabolic modulation, endoplasmic reticulum (ER) stress, and RNA virus restriction. Furthermore, with the expansion of the STING interactome, the details of STING trafficking also get clearer. After retrospecting the brief history of viral interference and the milestone events since the discovery of STING, we present a vivid panorama of STING biology taking into account the details of the biochemical assay and structural information, especially its versatile outputs and functions beyond IFN induction. We also summarize the roles of STING in the pathogenesis of various diseases and highlight the development of small-molecular compounds targeting STING for disease treatment in combination with the latest research. Finally, we discuss the open questions imperative to answer.

Development of small molecule inhibitors/agonists targeting STING for disease

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Agonists and Inhibitors of the Cgas-Sting Pathway

Cgas–sting, an Important Signaling Pathway in Diseases and Their Therapy

Bioactive Modulators Targeting STING Adaptor in Cgas-Sting Pathway

STING, a promising target for small molecular immune modulator: A review

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors

Cgas-Sting, an Important Pathway in Cancer Immunotherapy.

Agonists and Inhibitors of the STING Pathway: Potential Agents for Immunotherapy

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective

Recent advances in the development of STING inhibitors: an updated patent review

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Insight into the Dichotomous Regulation of STING Activation in Immunotherapy

Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments

STING inhibitors target the cyclic dinucleotide binding pocket

Nanoparticle targeting cGAS-STING signaling in disease therapy

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy